Objectives: To identify and analyze the characteristics of the most influential articles about central nervous system (CNS) inflammatory demyelinating disease.

Materials And Methods: The Institute for Scientific Information (ISI) Web of Science database and the 2014 Journal Citation Reports Science Edition were used to retrieve the top 100 cited articles on CNS inflammatory demyelinating disease. The citation numbers, journals, years of publication, authorships, article types, subjects and main issues were analyzed. For neuromyelitis optica (NMO), articles that were cited more than 100 times were regarded as a citation classic and described separately.

Results: The top 100 cited articles were published between 1972 and 2011 in 13 journals. The highest number of articles ( = 24) was published in followed by ( = 21). The average number of citations was 664 (range 330-3,897), and 64% of the articles were from the United States and the United Kingdom. The majority of the top 100 cited articles were related to multiple sclerosis ( = 87), and only a few articles reported on other topics such as NMO ( = 9), acute disseminated encephalomyelitis ( = 2) and optic neuritis ( = 2). Among the top 100 cited articles, 77% were original articles. Forty-one citation classics were found for NMO.

Conclusions: Our study provides a historical perspective on the research progress on CNS inflammatory demyelinating disease and may serve as a guide for important advances and trends in the field for associated researchers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474706PMC
http://dx.doi.org/10.1002/brb3.700DOI Listing

Publication Analysis

Top Keywords

inflammatory demyelinating
16
top 100
16
100 cited
16
cited articles
16
demyelinating disease
12
cns inflammatory
12
articles
10
citation classics
8
central nervous
8
nervous system
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!